This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2023 Nov 20;41(33):5077-5078.

doi: 10.1200/JCO.23.01109.

Flashback Foreword: Oxaliplatin Plus LV5FU2 in Colorectal Cancer

Robert J Mayer^{1

2}

Affiliations

Affiliations

¹ Former Associate Editor, Journal of Clinical Oncology, Alexandria, VA.
² Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

PMID: 37967514
DOI: 10.1200/JCO.23.01109

Editorial

Flashback Foreword: Oxaliplatin Plus LV5FU2 in Colorectal Cancer

Robert J Mayer. J Clin Oncol. 2023.

. 2023 Nov 20;41(33):5077-5078.

doi: 10.1200/JCO.23.01109.

Author

Robert J Mayer^{1

2}

Affiliations

¹ Former Associate Editor, Journal of Clinical Oncology, Alexandria, VA.
² Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

PMID: 37967514
DOI: 10.1200/JCO.23.01109

No abstract available

PubMed Disclaimer

Comment on

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.
de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A. de Gramont A, et al. J Clin Oncol. 2000 Aug;18(16):2938-47. doi: 10.1200/JCO.2000.18.16.2938. J Clin Oncol. 2000. PMID: 10944126 Clinical Trial.

References

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information